This is a preview of subscription content, log in via an institution to check access.
Notes
The BMJ has been trying to help the Cochrane Collaboration gain full access to data on oseltamivir. The Cochrane reviewers say there are at least 123 trials of oseltamivir and that 60% of the patient data from completed phase III trails remains unpublished.
References
Godlee F. Withdraw approval for Tamiflu until NICE has full data.BMJ : 12 Dec 2012. Available from: URL: http://dx.doi.org/10.1136/bmj.e8415
Rawlins M. We are asking more questions about NICE appraisal of Tamiflu.BMJ : 12 Dec 2012. Available from: URL: http://dx.doi.org/10.1136/bmj.e8420
NICE is urged to make drug companies supply all trial data.BMJ : 5 Dec 2012. Available from: URL: http://dx.doi.org/10.1136/bmj.e8294
Watt N. MPs call for investigation into ?500m spent on Tamiflu drug.The Guardian : 13 Dec 2012. Available from: URL: http://www.guardian.co.uk
Rights and permissions
About this article
Cite this article
BMJ asks NICE to withdraw approval for oseltamivir. PharmacoEconomics & Outcomes News 669, 2 (2013). https://doi.org/10.1007/s40274-013-0040-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0040-3